Baozun Inc. to Announce First Quarter 2017 Unaudited Financial Results on May 16, 2017
May 10, 2017 11:03 am UTC| Business
SHANGHAI, China, May 10, 2017 -- Baozun Inc. (Nasdaq:BZUN) ("Baozun" or the "Company"), the leading brand e-commerce service partner that helps brands execute their e-commerce strategies in China, today announced that...
Norwegian Cruise Line Holdings Reports Financial Results for the First Quarter 2017
May 10, 2017 11:02 am UTC| Business
Company Reports Record First Quarter Revenue of $1.2 Billion Strong Operating Environment Results in an Increase of Full Year Guidance Norwegian Joy, Custom-Built Ship for China, Joins Fleet MIAMI, May 10, 2017 --...
Norwegian Cruise Line Holdings Reports Financial Results for the First Quarter 2017
May 10, 2017 11:02 am UTC| Business
Company Reports Record First Quarter Revenue of $1.2 Billion Strong Operating Environment Results in an Increase of Full Year Guidance Norwegian Joy, Custom-Built Ship for China, Joins Fleet MIAMI, May 10, 2017 --...
Norwegian Cruise Line Holdings Reports Financial Results for the First Quarter 2017
May 10, 2017 11:02 am UTC| Business
Company Reports Record First Quarter Revenue of $1.2 Billion Strong Operating Environment Results in an Increase of Full Year Guidance Norwegian Joy, Custom-Built Ship for China, Joins Fleet MIAMI, May 10, 2017 --...
May 10, 2017 11:02 am UTC| Business
CAMBRIDGE, Mass. and SHANGHAI, China, May 10, 2017 -- Vericel Corporation (Nasdaq:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions,...
May 10, 2017 11:02 am UTC| Business
CAMBRIDGE, Mass. and SHANGHAI, China, May 10, 2017 -- Vericel Corporation (Nasdaq:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions,...
May 10, 2017 11:02 am UTC| Business
CAMBRIDGE, Mass. and SHANGHAI, China, May 10, 2017 -- Vericel Corporation (Nasdaq:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions,...